Bio-Rad Laboratories, Inc.
BIO
株式のランク
#2176
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
株価
$352.89
最終同期: 2026-10-16
時価総額
$9.44B
変化（1日）
-3.34%
変化（1年）
13.83%
国
US
取引 Bio-Rad Laboratories, Inc. (BIO)
カテゴリー
Healthcare
Bio-Rad Laboratories, Inc.（BIO）の営業利益率
October 2026 時点の営業利益率 TTM: 9.08%
Bio-Rad Laboratories, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 9.08% です。2023 年末時点では 12.65% でした。
Bio-Rad Laboratories, Inc. の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 9.08% | -13.36% |
| 2024 | 10.48% | -17.15% |
| 2023 | 12.65% | -26.54% |
| 2022 | 17.22% | 0.58% |
| 2021 | 17.12% | 3.44% |
| 2020 | 16.55% | 66.67% |
| 2019 | 9.93% | -309.49% |
| 2018 | -4.74% | -187.78% |
| 2017 | 5.40% | 110.12% |
| 2016 | 2.57% | -68.89% |
| 2015 | 8.26% | 19.71% |
| 2014 | 6.90% | -13.21% |
| 2013 | 7.95% | -37.70% |
| 2012 | 12.76% | -10.33% |
| 2011 | 14.23% | -3.46% |
| 2010 | 14.74% | 13.82% |
| 2009 | 12.95% | 24.88% |
| 2008 | 10.37% | 12.11% |
| 2007 | 9.25% | -19.35% |
| 2006 | 11.47% | 17.52% |
| 2005 | 9.76% | -2.30% |
| 2004 | 9.99% | -31.25% |
| 2003 | 14.53% | -5.59% |
| 2002 | 15.39% | 12.34% |
| 2001 | 13.70% | 48.91% |
| 2000 | 9.20% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.03% | -98.12% |
US
|
|
| 17.86% | -98.03% |
IE
|
|
| 22.03% | -97.57% |
US
|
|
| 21.46% | -97.64% |
US
|
|
| 0.00% | - |
DE
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。